AM Henao-Restrepo

Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014.

W. Hanekom, A. Hickey, R. Seder, 2015, Vaccine.

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential

T. Fleming, S. Ellenberg, E. Halloran, 2020, The Lancet.

WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross-reactivity of nCoV with SARS-CoV: January 24, 2020, Geneva, Switzerland

P. Horby, D. Vaughn, S. Ellenberg, 2020 .

COVID-19 vaccine trials should seek worthwhile efficacy

R. Peto, T. Fleming, I. Longini, 2020, The Lancet.